Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 77 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd., is a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases.
Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.
The underwriters were represented by Chaim Friedland (Partner) and Ari Fried (Partner).
